FindTrial
Sign In

Buphenyl Therapy for Byler's Disease

Compassionate Use of Buphenyl® in the Treatment of Byler's Disease

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT01784718
Enrollment
Unknown
Registered
2013-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2013-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Byler Disease

Brief summary

This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

Interventions

DRUGBuphenyl

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum

Inclusion criteria

* Byler Disease * Cholestasis unresponsive to pharmacologic therapy

Exclusion criteria

* Allergy/Hypersensitivity to Buphenyl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026